Fu Lijia, executive vice president of the Beijing Pharmaceutical Industry Association, said: “The name change means that the packaging materials, manuals, boxes, cartons, and labels all need to be changed.

Following the comprehensive revision of the cigarette packaging label on October 1 last year, the China Food and Drug Administration has planned to fully rectify the pharmaceutical packaging, and a large number of drug packaging will be reprinted.

On January 11th, the State Food and Drug Administration General Office publicly solicited opinions on the new regulations on Chinese patent medicines and requested them to be sent by e-mail to the designated mailbox of the General Administration of Customs. Pediatric Kechuanling, powerful hemorrhoids, quick rescue heart pill ... ... these familiar medicine names or will make a facelift.

A reporter survey found that according to the new regulations, thousands of drugs may need to be renamed. The State Food and Drug Administration stated that the work adheres to the following principles:

The first is strict specification. For the listed proprietary Chinese medicines, there are exaggerated curative effects, superstitious beliefs, and vulgar indecent language in the name, requiring the company to rename.

The second is the implementation of classification. Differentiate between listed products and newly declared products. For listed Chinese medicines, it is necessary to distinguish between exaggerated and implied curative effects or non-standardized curative effects, and will deal with non-standard issues step by step.

The third is a reasonable transition. Consider the actual situation of the company and take appropriate transition measures after the product is renamed.

If the new regulations are once implemented, some old proprietary Chinese medicines already on the market will be renamed. How widespread is this provision? In the column of Domestic Drugs of the Food and Drug Administration's Drug Database, the input part involves changes to the keywords. Thousands of drug approvals can be retrieved, of which there are more than 2,000 drugs with the word “spirit” in their light names. The pharmaceuticals of several listed pharmaceutical companies may involve renamed Tongrentang, Guizhou Braun, Zhongxin Pharmaceutical, China Resources Sanjiu, Tianmu Pharmaceutical and Shenwei Pharmaceutical.

Fu Lijia, executive vice president of the Beijing Pharmaceutical Industry Association, said: “The name change means that the packaging materials, manuals, boxes, cartons, and labels all need to be changed. The cost of production packaging can be calculated and endured, but for old brands, the name change brings The intangible loss is very large, and it also requires a lot of manpower and financial resources to cultivate the secondary market, so that consumers can know that the renamed product is the same old drug used."

If this new regulation is implemented, it will bring new business opportunities to the packaging and printing industry. Some old manuscripts, films, plates, and even crafts will be replaced by old ones. As a result, packaging material suppliers, printing consumables suppliers and equipment suppliers may become beneficiaries. For the current sluggish printing industry, it is undoubtedly a potent agent. (Source: China Packaging and Printing Industry Network)